Suppr超能文献

药代动力学/代谢组学-药效学揭示了复方中药保元汤抗心肌肥厚的协同作用机制。

Pharmacokinetics/pharmacometabolomics-pharmacodynamics reveals the synergistic mechanism of a multicomponent herbal formula, Baoyuan decoction against cardiac hypertrophy.

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People's Republic of China.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People's Republic of China.

出版信息

Biomed Pharmacother. 2021 Jul;139:111665. doi: 10.1016/j.biopha.2021.111665. Epub 2021 May 7.

Abstract

Multicomponent herbal formulas (MCHFs) have earned a wide reputation for their definite efficacy in preventing or treating chronic complex diseases. However, holistic elucidation of the causal relationship between the bioavailable ingredients of MCHFs and their multitarget interactions is very challenging. To solve this problem, pharmacokinetics/pharmacometabolomics-pharmacodynamics (PK/PM-PD) combined with a multivariate biological correlation-network strategy was developed and applied to a classic MCHF, Baoyuan decoction (BYD), to clarify its active components and synergistic mechanism against cardiac hypertrophy (CH). First, multiple plasma metabolic biomarkers for β-adrenergic agonist-induced CH rats were identified by using untargeted metabolomic profiling, and then, these CH-associated endogenous metabolites and the absorbed BYD-compounds in plasma at different treatment stages after oral administration of BYD were analyzed by using targeted PK and PM. Second, the dynamic relationship of BYD-related compounds and CH-associated endogenous metabolites and signaling pathways was built by using multivariate and bioinformatic correlation analysis. Finally, metabolic-related PD indicators were predicted and further verified by biological tests. The results demonstrated that the bioavailable BYD-compounds, such as saponins and flavonoids, presented differentiated and distinctive metabolic features and showed positive or negative correlations with various CH-altered metabolites and PD-indicators related to gut microbiota metabolism, amino acid metabolism, lipid metabolism, energy homeostasis, and oxidative stress at different treatment stages. This study provides a novel strategy for investigating the dynamic interaction between BYD and the biosystem, providing unique insight for disclosing the active components and synergistic mechanisms of BYD against CH, which also supplies a reference for other MCHF related research.

摘要

多组分草药配方(MCHF)因其在预防或治疗慢性复杂疾病方面的明确疗效而享有广泛声誉。然而,全面阐明 MCHF 的生物可利用成分与其多靶相互作用之间的因果关系极具挑战性。为了解决这个问题,开发了药代动力学/代谢组学-药效学(PK/PM-PD)结合多变量生物相关网络策略,并将其应用于经典的 MCHF,保元汤(BYD),以阐明其针对心肌肥厚(CH)的活性成分和协同作用机制。首先,通过非靶向代谢组学分析鉴定出β-肾上腺素能激动剂诱导的 CH 大鼠的多个血浆代谢生物标志物,然后通过靶向 PK 和 PM 分析口服 BYD 后不同治疗阶段的 BYD 相关吸收化合物和 CH 相关内源性代谢物。其次,通过多元和生物信息学相关分析构建了 BYD 相关化合物与 CH 相关内源性代谢物和信号通路的动态关系。最后,通过生物学测试预测和进一步验证了代谢相关 PD 指标。结果表明,生物可利用的 BYD 化合物,如皂苷和黄酮类化合物,表现出不同的代谢特征,并与不同治疗阶段的各种 CH 改变的代谢物和与肠道微生物代谢、氨基酸代谢、脂质代谢、能量平衡和氧化应激相关的 PD 指标呈正相关或负相关。这项研究为研究 BYD 与生物系统之间的动态相互作用提供了一种新策略,为揭示 BYD 对抗 CH 的活性成分和协同作用机制提供了独特的见解,也为其他 MCHF 相关研究提供了参考。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验